The FDA has approved the selective serotonin and norepinephrine dual reuptake inhibitor milnacipran (Savella) for fibromyalgia.

The FDA has approved the selective serotonin and norepinephrine dual reuptake inhibitor milnacipran (Savella) for fibromyalgia. Read the full article >>